➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Moodys
Dow
Colorcon
McKinsey

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Pyridoxal Phosphate


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Pyridoxal Phosphate?

Pyridoxal Phosphate is an investigational drug.

There have been 7 clinical trials for Pyridoxal Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2011.

The most common disease conditions in clinical trials are Movement Disorders, Dyskinesias, and Protoporphyria, Erythropoietic. The leading clinical trial sponsors are Medicure, Beersheva Mental Health Center, and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Recent Clinical Trials for Pyridoxal Phosphate
TitleSponsorPhase
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO DeficiencyMedicurePhase 3
Study of Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO DeficiencyMedicurePhase 3
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaIcahn School of Medicine at Mount SinaiN/A

See all Pyridoxal Phosphate clinical trials

Clinical Trial Summary for Pyridoxal Phosphate

Top disease conditions for Pyridoxal Phosphate
Top clinical trial sponsors for Pyridoxal Phosphate

See all Pyridoxal Phosphate clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Moodys
Express Scripts
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.